Genmab A/S (GMAB)
26.33
-0.71
(-2.63%)
USD |
NASDAQ |
May 29, 16:00
26.34
+0.02
(+0.06%)
After-Hours: 20:00
Genmab Shareholders Equity (Quarterly) : 5.682B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ascendis Pharma A/S | 562.24M |
| Zealand Pharma A/S | 2.231B |
| Bavarian Nordic A/S | 1.956B |
| Evaxion AS | 13.21M |
| Johnson & Johnson | 81.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.38B |
| Total Liabilities (Quarterly) | 6.694B |
| Debt to Equity Ratio | 0.9417 |
| Current Ratio | 2.184 |
| Net Debt Paydown Yield | -6.30% |